DEBENHAM GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: D83041 | STOWMARKET, IP14 6QU
Showing results 101-150 of 615
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Insulin aspart | 418 | 2,501 | £16.5K | +9.8% ▲ |
| Esomeprazole | 406 | 14.9K | £1.4K | +0.3% vs avg |
| Senna | 395 | 23.1K | £539 | -34.4% ▼ |
| Digoxin | 395 | 11.3K | £857 | +4.4% ▲ |
| Methotrexate | 390 | 9,813 | £605 | +19.8% ▲ |
| Solifenacin | 389 | 12.1K | £905 | -18.5% ▼ |
| Timolol and bimatoprost | 388 | 6,123 | £6.1K | +155.7% ▲ |
| 383 | 43.5K | £2.6K | +77.1% ▲ | |
| Cetirizine hydrochloride | 380 | 24.4K | £1.1K | -23.9% ▼ |
| Loperamide hydrochloride | 379 | 31.7K | £1.1K | +62.7% ▲ |
| Levetiracetam | 367 | 42.8K | £2.2K | -19.8% ▼ |
| Pravastatin sodium | 358 | 10.0K | £501 | +10.2% ▲ |
| Thiamine hydrochloride | 353 | 19.8K | £535 | -33.0% ▼ |
| Letrozole | 349 | 9,827 | £4.0K | +86.9% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 337 | 25.0K | £1.0K | +10.0% ▲ |
| Sacubitril/valsartan | 331 | 15.2K | £23.2K | +38.2% ▲ |
| Trimethoprim | 330 | 9,837 | £608 | +61.5% ▲ |
| 328 | 332 | £1.7K | +38.9% ▲ | |
| Carbamazepine | 324 | 27.7K | £1.7K | +9.2% ▲ |
| Dorzolamide and timolol | 318 | 7,995 | £4.9K | +122.2% ▲ |
| Lactulose | 312 | 200.4K | £1.7K | -5.2% ▼ |
| Buprenorphine | 312 | 1,806 | £4.9K | -14.8% ▼ |
| 308 | 2,993 | £1.2K | +23.4% ▲ | |
| Bimatoprost | 307 | 5,496 | £2.9K | +106.5% ▲ |
| Loratadine | 305 | 9,600 | £210 | +46.0% ▲ |
| 302 | 765 | £506 | +37.1% ▲ | |
| Quetiapine | 295 | 14.5K | £3.5K | -52.6% ▼ |
| 294 | 2,715 | £804 | +40.7% ▲ | |
| Betahistine hydrochloride | 291 | 25.9K | £881 | +21.9% ▲ |
| Other emollient preparations | 291 | 151.7K | £2.2K | -51.6% ▼ |
| Eplerenone | 288 | 8,097 | £1.0K | +8.6% ▲ |
| Glyceryl trinitrate | 286 | 1,057 | £999 | +20.9% ▲ |
| Clarithromycin | 279 | 6,756 | £1.4K | +13.7% ▲ |
| Carbocisteine | 270 | 43.0K | £1.1K | -49.4% ▼ |
| Tadalafil | 269 | 4,103 | £958 | +58.2% ▲ |
| Carbomer 940/980 | 267 | 5,910 | £1.1K | +75.3% ▲ |
| 266 | 52.5K | £1.4K | -43.9% ▼ | |
| Promethazine hydrochloride | 265 | 11.3K | £1.2K | -25.9% ▼ |
| Ispaghula husk | 263 | 12.0K | £2.0K | +99.7% ▲ |
| Fluticasone furoate | 258 | 264 | £1.8K | +33.2% ▲ |
| Aciclovir | 255 | 11.2K | £519 | +71.4% ▲ |
| Insulin glargine | 251 | 1,447 | £11.1K | -11.6% ▼ |
| Oxybutynin | 249 | 15.0K | £2.3K | +30.7% ▲ |
| Bumetanide | 247 | 11.7K | £1.2K | -9.3% ▼ |
| Nicorandil | 246 | 14.7K | £2.1K | +70.9% ▲ |
| Linagliptin | 243 | 6,804 | £7.4K | -40.7% ▼ |
| Semaglutide | 243 | 6,844 | £19.0K | +0.9% vs avg |
| Hydroxocobalamin | 243 | 288 | £589 | -49.5% ▼ |
| Aripiprazole | 239 | 6,792 | £881 | -6.1% ▼ |
| Fluticasone/umeclidinium/vilanterol | 233 | 233 | £9.5K | -0.6% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.